Anebulo Pharmaceuticals Inc

NASDAQ:ANEB   3:48:21 PM EDT
6.53
+0.26 (+4.14%)
Earnings Announcements

Anebulo Pharma Reports Q1 2022 Financial Results

Published: 11/12/2021 14:29 GMT
Anebulo Pharmaceuticals Inc (ANEB) - Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2022 Financial Results and Provides a Business Update.
Q1 Loss per Share $0.07.
Expects Topline Results to Be Available in First Half of 2022 for Aneb-001.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.06

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.07

More details on our Analysts Page.